Ernst Joel D, Trevejo-Nuñez Giraldina, Banaiee Niaz
Department of Medicine, Division of Infectious Diseases, New York University School of Medicine, New York, NY 10016, USA.
J Clin Invest. 2007 Jul;117(7):1738-45. doi: 10.1172/JCI31810.
Tuberculosis kills nearly 2 million people annually, and current approaches to tuberculosis control are expensive, have limited efficacy, and are vulnerable to being overcome by extensively drug-resistant strains of Mycobacterium tuberculosis. Determination of the genome sequence of M. tuberculosis has revolutionized tuberculosis research, contributed to major advances in the understanding of the evolution and pathogenesis of M. tuberculosis, and facilitated development of new diagnostic tests with increased specificity for tuberculosis. In this review, we describe some of the major progress in tuberculosis research that has resulted from knowledge of the genome sequence and note some of the problems that remain unsolved.
结核病每年导致近200万人死亡,目前的结核病控制方法成本高昂、疗效有限,且容易被广泛耐药的结核分枝杆菌菌株所攻克。结核分枝杆菌基因组序列的测定彻底改变了结核病研究,推动了对结核分枝杆菌进化和发病机制理解的重大进展,并促进了对结核病具有更高特异性的新诊断测试的开发。在这篇综述中,我们描述了一些因基因组序列知识而在结核病研究中取得的主要进展,并指出了一些仍未解决的问题。